ReWalk Robotics (NASDAQ:RWLK) Coverage Initiated by Analysts at StockNews.com

Equities research analysts at StockNews.com began coverage on shares of ReWalk Robotics (NASDAQ:RWLK – Get Rating) in a research note issued to investors on Monday. The brokerage set a “sell” rating on the medical device company’s stock.

Separately, HC Wainwright reissued a “buy” rating and issued a $3.00 price target on shares of ReWalk Robotics in a report on Friday, February 24th.

ReWalk Robotics Trading Up 1.4 %

Shares of NASDAQ RWLK opened at $0.62 on Monday. The company has a market cap of $36.66 million, a price-to-earnings ratio of -1.92 and a beta of 2.46. ReWalk Robotics has a 12-month low of $0.56 and a 12-month high of $1.14. The stock’s 50 day simple moving average is $0.65 and its 200 day simple moving average is $0.77.

ReWalk Robotics (NASDAQ:RWLK – Get Rating) last announced its quarterly earnings results on Thursday, February 23rd. The medical device company reported ($0.09) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.07) by ($0.02). The company had revenue of $2.18 million during the quarter, compared to the consensus estimate of $2.10 million. ReWalk Robotics had a negative return on equity of 27.12% and a negative net margin of 333.16%. As a group, equities analysts forecast that ReWalk Robotics will post -0.29 earnings per share for the current fiscal year.

Insider Buying and Selling at ReWalk Robotics

In other ReWalk Robotics news, major shareholder Global Fund Lp Lind II bought 102,098 shares of the business’s stock in a transaction on Monday, March 6th. The shares were purchased at an average price of $0.79 per share, with a total value of $80,657.42. Following the purchase, the insider now directly owns 4,963,633 shares of the company’s stock, valued at $3,921,270.07. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. 0.78% of the stock is owned by company insiders.

Institutional Trading of ReWalk Robotics

Several hedge funds have recently added to or reduced their stakes in the business. Renaissance Technologies LLC bought a new stake in shares of ReWalk Robotics in the 1st quarter worth $35,000. Millennium Management LLC raised its stake in shares of ReWalk Robotics by 78.6% in the 2nd quarter. Millennium Management LLC now owns 138,282 shares of the medical device company’s stock worth $130,000 after buying an additional 60,859 shares in the last quarter. Finally, Virtu Financial LLC raised its stake in shares of ReWalk Robotics by 249.6% in the 4th quarter. Virtu Financial LLC now owns 47,638 shares of the medical device company’s stock worth $36,000 after buying an additional 34,013 shares in the last quarter. Institutional investors own 4.44% of the company’s stock.

ReWalk Robotics Company Profile

(Get Rating)

ReWalk Robotics Ltd. Is a medical device company, which engages in the design, development and marketing of wearable robotic exoskeletons. The firm’s exoskeletons provide hip and knee motion to enable individuals with spinal cord injury (SCI) to stand upright, walk, turn, and climb and descend stairs.